CTI BioPharma (CTIC) Misses Q2 EPS by 9c
Get Alerts CTIC Hot Sheet
Price: $9.09 --0%
EPS Growth %: +100.0%
Financial Fact:
Total revenues: 4.43M
Today's EPS Names:
SHIM, KOD, HEWA, More
EPS Growth %: +100.0%
Financial Fact:
Total revenues: 4.43M
Today's EPS Names:
SHIM, KOD, HEWA, More
Join SI Premium – FREE
CTI BioPharma (NASDAQ: CTIC) reported Q2 EPS of ($0.19), $0.09 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $1.1 million, versus $1.3 million reported last year.
For earnings history and earnings-related data on CTI BioPharma (CTIC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- NaaS Technology Inc. (NAAS) Reports Q1 Loss of $0.29
- Dolphin Entertainment, Inc. (DLPN) Misses Q4 EPS by 33c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!